Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Calcium and osteoporosis

This article was originally published in The Tan Sheet

Executive Summary

Twenty-one percent (367) of 1,743 women surveyed take calcium supplements, although 92% had heard of osteoporosis and 24.7% had been tested for it, according to results of the Massachusetts Department of Public Health's 1997 Behavioral Risk Factor Surveillance Survey released June 11. Of the 358 women asked how often they take calcium, 68.6% said every day, 15.2% responded some days and 16.3% answered less than half the month. The survey found that 3.8% of those questioned have been told they have osteoporosis. People "are aware of osteoporosis, but aren't making lifestyle choices to prevent the disease," the DPH osteoporosis awareness program says. Recommended calcium intake for adults under the Food & Nutrition Board's new Dietary Reference Intakes, issued in August 1997, are 1,000-1,200 mg daily, depending on age ("The Tan Sheet" Aug. 18, 1997, pp. 14-16)...
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088552

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel